Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
If you miss the 45-day window for doses 7.5 mg and above, you'll pay the standard self-pay price for that refill: 7.5 mg: $599 , 10 mg: $699 , 12.5 mg: $849 , 15 mg: $1,049
Abstract Whilst the prevalence of obesity continues to increase at an alarming rate worldwide, the personal and economic burden of obesity-related complications becomes ever more important
Nonetheless, it is essential to recognize some distinctions between these two drugs
Key Market Growth Drivers Rapid rise in global type 2 diabetes prevalence Strong clinical outcomes in glycemic control and weight reduction Expanding use in obesity and cardiometabolic risk management Innovation in weekly injectables and oral GLP-1 formulations Growing patient preference for dual-benefit metabolic therapies Key Players in the GLP-1 Diabetes Treatment Drugs Market Eli Lilly and Company Sanofi Novo Nordisk Beijing Hanmi Pharmaceutical Co., Ltd
Always buy from trusted websites to avoid fake products
